Dentsply Sirona

DENTSPLY Sirona reported revenue of $898 million in the second quarter, slightly above consensus but down year‑on‑year (nominal -4.1%, constant currency -6.3%). Adjusted EPS was $0.52, flat versus the prior year (excluding tariff refunds), and operating cash flow rose to $99 million thanks to tariff refunds and working capital improvements. Management reaffirmed the full‑year guidance but warned of a weaker third quarter before an expected recovery in the fourth quarter; investors reacted negatively and pushed the stock sharply lower. The company is continuing its 24‑month “Return‑to‑Growth” plan and investing in sales, clinical education and R&D, but sees persistent weakness in the U.S. implant and orthodontics businesses. » More on de.investing.com

Ariel Focus Fund disclosed adding DENTSPLY SIRONA to its Q2 2026 portfolio, citing the dental market's steady growth and lower reimbursement risk. The fund noted DENTSPLY SIRONA's capital equipment business has been pressured by lower-cost alternatives and higher financing costs, but highlighted management's strategic reset focused on debt paydown, product innovation, portfolio expansion, operational efficiencies and bolt-on acquisitions. Ariel expects these initiatives to improve margins and position the company to capitalize on secular growth trends. » More on finance.yahoo.com

DENTSPLY SIRONA will pay a dividend of $0.64 for fiscal year 2025, totaling $128.00 million, unchanged from the previous year. The dividend yield for 2025 is 5.60% based on a closing price of $9.83 on the day of the annual general meeting, compared with 3.37% in the prior year. Over one year the share price fell by 38.14%, and total return (price plus dividend) is -2.89%. FactSet expects a sharp cut to $0.06 per share for 2026, which would push the dividend yield down to around 0.65%. » More on finanzen.net

Dentsply Sirona is extending its partnership with Nashville Dental, allowing the company as of August 1, 2026 to add connected technologies such as the CEREC system, Primescan intraoral scanners and digital imaging to its portfolio. The expanded agreement covers sales and service in nine U.S. states and is intended to ensure local installation, maintenance and practice consulting by Nashville Dental. The move is part of Dentsply Sirona’s U.S. strategy to bring connected solutions closer to customers through a combined direct and indirect sales approach. » More on de.investing.com

Dentsply Sirona reported net sales of $880 million for Q1 2026 (reported increase 0.1%), while constant-currency revenue fell by 6.7%. Adjusted EBITDA declined 22.8% to $129 million and adjusted earnings per share fell 39% to $0.27. Operating cash flow rose significantly, but free cash flow remained negative at -$12 million. Management confirmed the full-year guidance and announced a "Return-to-Growth Action Plan", product innovations and restructuring measures, as well as debt reduction and inventory optimization. » More on de.investing.com